Close Menu

NEW YORK – Predictive Oncology said Friday that it has reached agreements with investors for a direct offering of more than 3.4 million shares at $1.20 per share, for gross proceeds of approximately $4.1 million.

The firm also has agreed to issue investors slightly more than 1.7 million warrants at $1.37 per share. These warrants will expire 5.5 years from issuance.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.